Crews Bank & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$438K Buy
18,187
+289
+2% +$7.56K 0.06% 161
2026
Q1
$503K Sell
17,898
-3
-0% -$80 0.07% 145
2025
Q4
$446K Sell
17,901
-760
-4% -$19.2K 0.06% 154
2025
Q3
$475K Sell
18,661
-100
-0.5% -$2.47K 0.07% 149
2025
Q2
$455K Sell
18,761
-1,305
-7% -$30.4K 0.07% 147
2025
Q1
$508K Sell
20,066
-62
-0.3% -$1.62K 0.09% 133
2024
Q4
$534K Buy
+20,128
New +$546K 0.09% 127

Other funds holding PFE

Crews Bank & Trust's PFE Position: Q2 2026 in Review

Crews Bank & Trust increased its Pfizer (PFE) stake by 1.6% in Q2 2026, buying an estimated $7.56K and bringing the position to 18,187 shares worth $438K. The position accounts for 0.06% of the portfolio, ranked #161.

Crews Bank & Trust first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $534K in Q4 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Crews Bank & Trust held 18,187 shares of Pfizer worth $438K as of Q2 2026.
  • Crews Bank & Trust bought 289 Pfizer shares in Q2 2026, an estimated $7.56K.
  • Pfizer made up 0.06% of Crews Bank & Trust's portfolio in Q2 2026, its #161 holding.
  • Crews Bank & Trust first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Crews Bank & Trust's Pfizer position peaked at $534K in Q4 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.